Objective:

Develop a filtration-based diagnostic platform to detect low concentrations of bacteria and assess antibiotic susceptibility rapidly.

Approach:

• Platform: A gold-nanostructure-coated glass microfiber filter captures and concentrates bacteria from liquid samples. Additional gold particles are grown around captured cells to amplify their surface-enhanced Raman scattering signals.
• Evaluation: Researchers tested bacterial detection and antibiotic-response assessment using E. coli as a model organism, and demonstrated species identification for E. coli, Staphylococcus aureus, and Klebsiella pneumoniae.

Key Findings:

• For E. coli at the tested concentrations, capture efficiency exceeded 99.9%.
• The platform detected 1,000 CFU/mL; adding a 1-hour culture step improved sensitivity to 10 CFU/mL.
• Molecular fingerprints distinguished E. coli, Staphylococcus aureus, and Klebsiella pneumoniae.
• Within 2 hours, E. coli signals declined after amikacin exposure, indicating susceptibility, and continued increasing after ampicillin exposure, indicating reduced susceptibility.

Interpretation:

The study reports a platform that combines bacterial detection with rapid assessment of antibiotic response. The authors describe it as a potential route to faster diagnosis and more informed antimicrobial decisions.

Limitations:

• E. coli was used as the model organism for the capture and antibiotic-response demonstrations; species identification was demonstrated for three bacterial species.
• Validation with patient blood samples and a broader range of pathogens remains necessary.

Conclusion:

The platform detected and characterized bacteria in laboratory testing, but further validation is needed.

Sources:

• Article context; study published in Small Methods